Perspectives

September 12, 2018

Seeking Alpha

Dosing underway in Apellis Pharma's late-stage program of APL-2 in geographic a…

September 12, 2018

Healio

Apellis begins phase 3 clinical program for geographic atrophy treatment

August 31, 2018

Retinal Physician

SUBSPECIALTY NEWS: Sustained-release drug, 12-week dosing, and more

August 23, 2018

Boston Business Journal

Kentucky biotech Apellis plans major expansion in Mass

July 28, 2018

Healio, Ocular Surgery News

Apellis begins phase 3 clinical program for geographic atrophy program

July 24, 2018

Endpoints News

FDA hands Apellis Pharmaceuticals fast track designation for its advanced dry A…

July 24, 2018

Healio, Ocular Surgery News

Fast track designation granted for Apellis’ geographic atrophy treatment

July 22, 2018

Medscape

New Geographic Atrophy Treatment Shows Promise

July 22, 2018

Modern Retina

What APL-2 means for geographic atrophy

June 28, 2018

Endpoints News

As Alexion fields applications for ALXN1210, a rival aims for the crown with h…